Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 10/20 | 0.46 |
| ▸ | NPC1 | O15118 | 9/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.38 |
| ▸ | WNT3A | P56704 | 1/20 | 0.38 |
| ▸ | PLK1 | P53350 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Chromafenozide SCHEMBL73335 | 0.80 | ABCB1 (0.56) | CYP2C19CYP3A4 | |
| SCHEMBL7121475 | 0.80 | ABCB1 (0.48) | CYP3A4 | |
| SCHEMBL7041343 | 0.80 | MTNR1A (0.36) | RAB9ANPC1ALDH1A1MAPTCYP2C19 | |
| Hydrochloric Acid SCHEMBL8876046 | 0.79 | MTNR1A (0.35) | RAB9ANPC1ALDH1A1MAPTCYP2C19 | |
| SCHEMBL7130710 | 0.77 | NPC1 (0.38) | RAB9ANPC1ALDH1A1MAPTCYP2C19 | |
| SCHEMBL7476564 | 0.76 | SMN1; SMN2 (0.41) | RAB9ANPC1ALDH1A1SMN1; SMN2CTNNB1 | |
| SCHEMBL7475290 | 0.75 | NPC1 (0.33) | RAB9ANPC1ALDH1A1MAPTCYP2C19 | |
| SCHEMBL7478893 | 0.74 | CTNNB1 (0.40) | RAB9ANPC1ALDH1A1MAPTCYP2C19 | |
| SCHEMBL7474498 | 0.71 | NPC1 (0.33) | RAB9ANPC1ALDH1A1MAPTCYP2C19 | |
| SCHEMBL9253142 | 0.70 | NPC1 (0.34) | RAB9ANPC1ALDH1A1MAPTCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110275583-A1 | Synergistic active compound combinations | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275583-A1 | Synergistic active compound combinations | ACHE, ACAT2, ACAT1 | RAB9A 196/4885NPC1 210/4885ALDH1A1 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.